Dahm et al., 8 in a study of 85 patients treated with different modalities, did not find significant OS differences; however, survival in p16-positive patients was better even if the difference did not reach statistical significance by two years.
← all excerpts
Role of P16 Expression in the Prognosis of Patients With Laryngeal Cancer: A Single Retrospective Analysis.
1
—
—